22 results
424B1
KPRX
Kiora Pharmaceuticals Inc
2 Jun 23
Prospectus with pricing info
5:08pm
Solution: KIO-101
KIO-101 is a third-generation small molecule DHODH inhibitor. DHODH is extensively exploited as potential drug targets for immunological
FWP
KPRX
Kiora Pharmaceuticals Inc
15 May 23
Free writing prospectus
5:18pm
-101: Selectively Targets T-Cell Mediated Inflammation in the Eye *Dihydroorotate Dehydrogenase ‡ Sanofi 10-K 2022 KIO-101 has Demonstrated Greater
424B3
zkv42jmnxtm2mmax
28 Dec 22
Prospectus supplement
4:48pm
424B1
cir542374ei1
22 Jul 22
Prospectus with pricing info
6:00pm
424B3
2oi m8yghxzm4s8sa2zy
30 Apr 21
Prospectus supplement
5:01pm